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Introduction 
Development of antibiotic resistance in bacteria has become a serious threat to public health, and 
a new class of antibiotics is needed to treat resistant bacteria. AMPs are molecules of host-
defense system and have been proposed as a novel class of anti-infectives. Considerable efforts 
have been allocated for developing AMP-based therapeutic strategies against pathogens. 
Despite the clinical importance of AMPs, the vital concern is that therapeutic use of AMPs holds 
the risk of cross-resistance to our own immunity peptides. This is an alarming issue as many 
AMP-based clinical applications are about to reach clinical trials while others are already in clinical 
use. But are all classes of AMPs equally prone to induce such cross-resistance effects? Our 
knowledge on the potential for cross-resistance between AMPs remains extremely limited. While 
most of our knowledge on AMP resistance is coming from case studies focusing on specific AMP, 
a systematic study on the extent to which the genetic determinants of resistance differ across 
AMPs is still lacking. Given the therapeutic importance of AMPs, a systematic study on AMP 
resistance, cross-resistance and collateral sensitivity (evolution of resistance to one drug 
increases sensitivity to other drugs) between AMPs may help to rationally choose AMPs for 
clinical development and to minimize the cross-resistance between therapeutic and human host 
AMPs. 
 To this end, we applied a genome-wide chemical-genetic approach to map the genetic 
determinants of AMP resistance in E. coli. This approach provides a better understanding of how 
the differences in mode of action of AMPs shape the resistance mechanisms against them. By 
analyzing these differences, we could identify a number of genes that induce cross-resistance 
and collateral sensitivity between AMPs. Moreover, by integrating laboratory evolution approach 
we demonstrated that chemical-genetic profiles can inform on cross-resistance patterns between 
AMPs. In future, the chemical-genetic map could inform on how to choose therapeutic AMPs with 
minimal cross-resistance to human host AMPs. 
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Aims 
 
In our research, we aimed to systematically investigate the latent and intrinsic AMP resistome of 
E. coli and to understand how the mode of action of AMPs shapes the resistome.  
 Our particular goals were the following: 1) identifying the resistance determinants of E. 
coli against 15 different AMPs, 2) understanding how the AMPs with different modes of action 
and physicochemical properties differ in their resistance determinants, 3) investigating whether 
the differences in AMP’s mode of action and resistance determinants advise on cross-resistance 
and collateral sensitivity interaction between AMPs. 
 
To achieve these goals, 
 we established a genome-wide chemical-genetic screening method to measure the effect 
of overexpression of each of 4,400 E. coli genes on bacterial susceptibility against 15 
AMPs (latent AMP resistome). 
 we explored the intrinsic AMP resistome by performing a chemical-genetic screen with a 
set of 279 partially-depleted essential genes (hypomorphic alleles) of E. coli. 
 we examined how the similarity in chemical-genetic profiles inform on mechanism of action 
of AMPs. 
 we interrogated whether the mode of action of AMPs shapes the latent and intrinsic 
resistome. 
 we investigated collateral sensitivity between AMPs and the molecular mechanism 
underlying collateral sensitivity interactions. 
 we investigated whether chemical-genetic profiles can inform on cross-resistance 
interactions between AMPs. 
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Methods 
1. Chemical-genetic screening 
We carried out chemical-genetic profiling to determine the impact of the overexpression of each 
E. coli ORF on bacterial susceptibility to each of the 15 different AMPs. To this end, we used the 
ASKA plasmid library (GFP minus) where each E. coli ORF is cloned into a high copy number 
expression plasmid (pCA24N-ORFGFP(-)). We applied a pooled fitness assay with a deep 
sequencing readout. The pooled overexpression library and the control strain were grown in the 
absence and presence of AMP. Following approximately 12-15 generations of logarithmic growth, 
next-generation sequencing was applied on the resulting plasmid pool to measure the relative 
abundance of each overexpression strain in the populations. 
2. High-throughput sequencing of plasmid pool 
To determine the relative abundance of each overexpression strain, the purified plasmid DNA 
samples were subjected to next-generation sequencing with SOLiD system (Life Technologies). 
DNA sequencing was carried out by István Nagy and his colleagues from Seqomics Ltd, Szeged.  
3. Data analysis and clustering of chemical-genetic profiles 
Data analysis and clustering of chemical-genetic profiles were performed by my colleague 
Gergely Fekete. Following different steps of data normalization and transformation, a differential 
growth score (i.e. fold-change) was calculated for each gene as the ratio of the normalized relative 
read counts in treated and non-treated samples at the end of the competition assay. Genes that 
showed at least 2-fold lower and higher relative abundance with a p-value<0.05 at the end of the 
competition upon AMP treatment were considered as sensitizing and resistance-enhancing 
genes, respectively.  
 We employed an ensemble clustering method to group the AMPs on the basis of their 
chemical-genetic profiles similarity. This method calculates distance between chemical-genetic 
profiles of AMPs, and then generates multiple clustering based on perturbing the AMP chemical-
genetic interaction data and the clustering parameters. Next, it combines the resulting clusters to 
obtain a consensus clustering which is robust and the best representative of multiple clustering.  
4. Chemical-genetic profiling of hypomorphic alleles 
Construction and chemical-genetic profiling of the hypomorphic alleles was carried out by our 
collaborator Mohan Babu and his colleagues at University of Regina, Regina, Canada 
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5. Calculating physicochemical properties of AMPs 
For each AMP, different physicochemical properties (like amino acid frequency, isoelectric point, 
hydrophobicity, net charge) were calculated. These calculations were made by my colleague 
Ádám Györkei. An in-house perl script was used to count protein amino acid frequencies. 
Isoelectric point, hydrophobicity, hydrophobic moment and net charge was calculated with the 
peptides R package, version 2.462. AMP length and molecular weight were calculated using the 
ExPasy Prot Param tool. The alpha-helical content and the disordered structure of AMPs were 
calculated using PASTA 2.0 server. 
6. Calculating the overlap in resistance-enhancing and sensitivity-enhancing genes 
between AMP pairs 
To calculate the overlap in resistance and sensitivity genes between AMP pairs, we used a 
modified version of the Jaccard index that takes into account measurement noise. For each AMP 
pair, we calculated the Jaccard index of overlap between the resistance gene sets and performed 
a correction by dividing this value by the average Jaccard index of overlap between replicate 
screens of the same AMPs. Corrected Jaccard indices were calculated separately for resistance 
and sensitivity genes. 
 
7. Enrichment analysis of collateral sensitivity-inducing genes 
For each AMP pair, overrepresentation of collateral sensitivity-inducing genes was calculated 
over random expectation. 
8. Gene ontology (GO) enrichment analysis of resistance-enhancing and sensitivity-
enhancing genes 
Biological Networks Gene Ontology tool (BiNGO) was used to determine which Gene-ontology 
(GO) terms are significantly enriched in the resistance-enhancing and sensitivity-enhancing 
genes. 
 
9. Minimum inhibitory concentration (MIC) measurement 
Minimum inhibitory concentrations (MIC) were determined with a standard serial broth dilution 
technique with a minor modification. Specifically, instead of a two-fold dilution series, smaller 
steps of AMP concentration were used (typically 1.2-fold) to capture small changes in the growth 
inhibition. 
10. Measurement of membrane surface charge 
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To measure bacterial membrane surface charge, we performed a fluorescein isothiocyanate-
labelled poly-L-lysine (FITC-PLL) (Sigma) binding assay. FITC-PLL is a polycationic molecule that 
is used to study the interaction between cationic peptides and anionic lipid membranes. The lower 
the amount of bound FITC-PLL, the less negatively charged the cell surface. 
11. Membrane potential measurement 
BacLight™ Bacterial Membrane Potential Kit (Invitrogen) was used to measure transmembrane 
potential (Δψ). In this assay, a fluorescent membrane potential indicator dye (DiOC2) exhibits 
green fluorescence in all bacterial cells and the fluorescence shifts to red in the cells that maintain 
a high membrane potential. The ratio of red/green fluorescence provides a measure of membrane 
potential. 
12. Growth curve measurement 
To determine the difference in bacterial growth in the presence of an AMP, we performed growth 
curve analysis. Growth curve measurement for the overexpression strains was done by 
measuring OD600 of the liquid bacterial cultures at different time points in a standard 96-well plate 
containing a 12-step dilution series of the tested AMP in MS medium. 
 
13. Construction of mlaD mutant 
We constructed mlaD knockout mutant of E. coli BW25113 by removing the kanamycin resistance 
cassette present in the position of the gene in mlaD knockout strain from KEIO collection. This 
mutation was performed by my colleague Csörgő Bálint. 
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Results 
1. Chemical-genetic profiling and its validation 
We performed a genome-wide overexpression screen to examine the effect of overexpression of 
each of 4,400 E. coli genes on bacterial susceptibility against a set of 15 AMPs. The AMPs used 
in this study are diverse in their physicochemical properties, mechanism of action and importantly 
some of them have clinical relevance. Next, we tested the accuracy of our chemical-genetic 
workflow by applying three different approaches. First, we tested correlation of chemical-genetic 
interaction scores between replicates. We found that the overall correlation was good (r = 0.63 
from Pearson’s correlation) and was in agreement with previous studies, showing reproducibility 
of chemical-genetic interactions. Second, we randomly selected 19 overexpression strains and 
determined minimum inhibitory concentrations (MIC) of the interacting AMPs. In total, we 
performed 92 measurements representing 4-5 AMPs per strain on average. In total, 83% cases 
showed a MIC difference in the expected direction, demonstrating that the majority of the 
chemical-genetic interactions can be confirmed by an independent experiment. Third, we 
compared the chemical-genetic interactions with literature curated list of resistance determinants 
in E. coli. To this end, we collected those genes that provide resistance or sensitivity to AMPs 
when overexpressed in E. coli. We found that 70 % of the 13 cases were in agreement with our 
chemical-genetic screen. Altogether, these results show the high sensitivity of our workflow in 
determining chemical-genetic interactions between AMPs and gene overexpression. 
2. Chemical-genetic profiles group AMPs with similar mechanisms of action and 
physicochemical properties 
We next tested whether AMPs with similar mechanistic and physicochemical properties cluster 
together based on their chemical-genetic profiles. We performed consensus clustering analysis 
using the chemical-genetic interaction profiles of AMPs. This analysis grouped the 15 AMPs into 
four different clusters (referred to as C1-C4). We found that membrane-targeting and intracellular-
targeting AMPs grouped into separate chemical-genetic clusters. Notably, membrane-targeting 
(C1and C2) and intracellular-targeting AMPs (C3 and C4) can also be differentiated based on 
their physicochemical properties. Our results suggest that similarity in chemical-genetic profiles 
reflects similarity in broad mechanisms of action and physicochemical properties of AMPs. 
Therefore, chemical-genetic profiles can capture subtle differences in how these AMPs interact 
with the bacterial cell. 
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3. A large and functionally diverse set of genes modulate bacterial susceptibility to 
AMPs 
Our chemical-genetic screen revealed that a large number of functionally diverse genes modulate 
AMP resistance in bacteria. These results substantially broaden the scope AMP resistance 
modulating genes, as a small fraction of resistance genes has been reported previously. 
Furthermore, we found that resistance-enhancing genes substantially differ across the AMPs with 
different modes of action. The differences in the chemical-genetic profiles were prominent 
between AMPs with different modes of action. In particular, resistance-enhancing genes showed 
significantly low overlap between membrane (C1 and C2)- and intracellular-targeting AMPs (C3 
and C4). These results reveal that AMPs differ considerably in their resistance determinants and 
these differences are shaped by mechanistic action of AMPs. 
4. Partial depletion of essential genes reveals the intrinsic AMP resistome 
Resistance upon gene overexpression informs on latent resistome while sensitivity upon gene 
depletion reveals intrinsic resistome. To investigate the intrinsic AMP resistome, we carried out a 
chemical-genetic screen with a set of 279 partially-depleted essential genes (hypomorphic alleles) 
of E. coli. We found that 75% of tested hypomorphic alleles show chemical-genetic interaction 
with at least one AMPs. AMPs with similar modes of action showed substantial overlap in their 
intrinsic resistomes whereas this overlap was significantly lower between functionally dissimilar 
AMPs. These findings reflected differences in the resistance determinants between AMPs, and 
showed that mode of action of AMPs shapes both the intrinsic and the latent AMP resistomes. 
 
5. Collateral sensitivity interactions are frequent between functionally dissimilar 
AMPs 
The limited overlap in resistance determinants across AMPs prompted us to hypothesize that 
some of the gene overexpressions might even show collateral sensitivity between AMPs. 
Interestingly we found that collateral sensitivity-inducing genes are widespread. Notably, 
collateral sensitivity interactions were significantly overrepresented between C1, C2 (membrane 
targeting) and C3, C4 (intracellular targeting) AMP clusters. 
6. Perturbed phospholipid trafficking as a mechanism underlying the collateral 
sensitivity interactions between AMPs 
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Next, we investigated the underlying molecular mechanism of the observed collateral sensitivity 
interactions between membrane-targeting and intracellular-targeting AMPs. By studying four 
different mutants including mlaD, a member of clinically relevant phospholipid transport pathway, 
we demonstrated that decreased negative surface charge and increased membrane potential 
result in collateral sensitivity between membrane- and intracellular-targeting AMPs. Decreased 
negative surface charge results in weaker electrostatic interactions between bacterial membrane 
and membrane-targeting AMPs and therefore confers resistance against membrane-targeting 
AMPs. At the same time, the increased membrane potential helps in translocation of intracellular-
targeting AMPs inside the bacterial cell and in exerting their antimicrobial activity.  
7. Chemical-genetic profiles inform on cross-resistance spectra of AMPs 
Since bacterial susceptibility can be defined by different gene sets for AMPs with distinct modes 
of action, we hypothesized that chemical-genetic profiles that differentiate these AMPs can advise 
on the cross-resistance spectrum. To test our hypothesis, we used our recently published dataset 
of antimicrobial susceptibility profiles of AMP-evolved lines. By integrating this comprehensive 
dataset with chemical-genetic profiles of AMPs, we identified that cross-resistance interactions 
(at 2-fold MIC increase) were significantly overrepresented between exclusively membrane-
targeting AMPs or between exclusively intracellular-targeting AMPs. Interestingly, the chemical-
genetic clustering provided additional insights into the cross-resistance patterns that could not 
have been predicted based on the broad mode of action of AMPs. Altogether, these results 
demonstrate that chemical-genetic profiles capture subtle differences in resistance determinants 
between AMPs with similar broad modes of action, and therefore inform on cross-resistance 
patterns between AMPs.  
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